Companies / Algeria
EIPICO Looks Abroad
June 2008 | Company News AlertEgypt's unfavourable regulatory environment is forcing the Egyptian International Pharmaceutical Industries Company (EIPICO) to look abroad for growth, according to company chairman Ahmed Borhan El-Din Ismail. EIPICO is one of Egypt's largest drugmakers, with an 8% share of the country's US$1.75bn pharmaceutical market, so BMI expects the threat to move some production overseas to be taken seriously by a government that puts a strong emphasis on local
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
